The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient ...

As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...

In the final part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, predicts ...

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how ...

State Medicaid leaders create a plan to ensure safety, affordability, and equitable access for children and families living ...

In response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical trials, key opinion leaders emphasize finding cost-effective approaches, ...

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

The Antibody-Drug Conjugate Renaissance A recent Pharmaceutical Executive article highlights how antibody-drug conjugates are experiencing a renaissance in oncology, with innovations in targeting, ...

Key Takeaways DHL has acquired Cryoport’s specialty courier business, CRYOPDP, for approximately $200 million, strengthening its position in temperature-controlled logistics for the life sciences ...

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines "smart pharma packaging" as the integration of technology into pharmaceutical packaging to enhance product ...

Key Takeaways Alzheimer’s disease affects nearly 6.9 million older U.S. adults, making it the most common form of dementia and a leading cause of long-term care needs and disability. The economic ...

Transforming Care for COPD: Q&A with Barry Quart In an interview with Pharmaceutical Executive, Barry Quart, CEO, Connect Biopharma, discussed his decision to join the company to advance ...